Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Dec;51(12):3200–3215. doi: 10.1172/JCI107147

Renal Transplantation between HL-A Identical Donor-Recipient Pairs

FUNCTIONAL AND MORPHOLOGICAL EVALUATION

H F Seigler 1,2,3,4,5, J C Gunnells Jr 1,2,3,4,5, R R Robinson 1,2,3,4,5, F E Ward 1,2,3,4,5, D B Amos 1,2,3,4,5, D T Rowlands 1,2,3,4,5, P M Burkholder 1,2,3,4,5, W J Klein 1,2,3,4,5, D L Stickel 1,2,3,4,5
PMCID: PMC333002  PMID: 4565678

Abstract

16 patients underwent renal transplantation from a sibling donor who was prospectively determined to be ABO compatible and HL-A identical with the recipient. Unidirectional mixed leukocyte reactions were performed; in each instance, lymphocyte stimulation in either direction was not observed.

The plasma creatinine 10-68 months after transplantation in these 16 patients ranged between 0.9 and 1.9 mg/100 ml. The creatinine clearance ranged from 48 to 113 ml/min, and the blood urea nitrogen (BUN) ranged between 12 and 35 mg/100 ml. Urine protein excretion varied from 0.11 to 1.86 g/day. Six patients exhibited no detectable clinical episodes of acute rejection; they were treated with azathioprine alone and each of them demonstrated normal or near normal renal histology when biopsy specimens were obtained more than 6 months after transplantation. Nine patients experienced acute rejection episodes that required the use of steroid therapy. The severity of these rejection episodes was variable; they included a mild reduction in renal function with an immediate steroid-induced restoration of function and eventual discontinuance of steroid therapy to severe reduction in function requiring prolonged and moderate doses of steroids without return to normal renal function. Renal histological observations in this group ranged from mild to marked cellular and structural changes which fit the criteria of the rejection. One patient demonstrated a gradual loss of renal function with heavy proteinuria. Biopsy of this allograft demonstrated the recurrence of original disease, i.e., lobular glomerulonephritis.

The marked variability in the clinical course and allograft morphology in these 16 patients could be explained by antigenic differences at non-HL-A loci. The presence of minor histocompatibility loci has been well documented in other mammalian species and they are most certainly present in man. The need for their identification and definition is stressed.

Full text

PDF
3200

Images in this article

3207Image
on p.3207
3207Image
on p.3207
3208Image
on p.3208
3208Image
on p.3208
3208Image
on p.3208
3208Image
on p.3208
3208Image
on p.3208
3210Image
on p.3210
3211Image
on p.3211
3211Image
on p.3211
3211Image
on p.3211
3211Image
on p.3211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos D. B., Bashir H., Boyle W., MacQueen M., Tiilikainen A. A simple micro cytotoxicity test. Transplantation. 1969 Mar;7(3):220–223. doi: 10.1097/00007890-196903000-00023. [DOI] [PubMed] [Google Scholar]
  2. Amos D. B. Genetic and antigenetic aspects of human histocompatibility systems. Adv Immunol. 1969;10:251–297. doi: 10.1016/s0065-2776(08)60419-8. [DOI] [PubMed] [Google Scholar]
  3. Amos D. B., Seigler H. F., Southworth J. G., Ward F. E. Skin graft rejection between subjects genotyped for HL-A. Transplant Proc. 1969 Mar;1(1):342–346. [PubMed] [Google Scholar]
  4. Bach F. H., Amos D. B. Hu-1: Major histocompatibility locus in man. Science. 1967 Jun 16;156(3781):1506–1508. doi: 10.1126/science.156.3781.1506. [DOI] [PubMed] [Google Scholar]
  5. Bach F. H., Kisken W. A. Predictive value of results of mixed leukocyte cultures for skin allograft survival in man. Transplantation. 1967 Jul;5(4 Suppl):1046–1052. doi: 10.1097/00007890-196707001-00039. [DOI] [PubMed] [Google Scholar]
  6. Dausset J., Walford R. L., Colombani J., Legrand L., Feingold N., Barge A., Rapaport F. T. The HL-A system sub-loci and their importance in transplantation. Transplant Proc. 1969 Mar;1(1):331–338. [PubMed] [Google Scholar]
  7. Dutton R. W. Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice. J Exp Med. 1966 Apr 1;123(4):665–671. doi: 10.1084/jem.123.4.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eijsvoogel V. P., Schellekens P. T., Breur-Vriesendorp B., Koning L., Koch C., van Leeuwen A., van Rood J. J. Mixed lymphocyte cultures and HL-A. Transplant Proc. 1971 Mar;3(1):85–88. [PubMed] [Google Scholar]
  9. FOSTER P. W., RICK J. J., WOLFSON W. Q. Studies in serum proteins. VI. The extension of the standard biuret method to the estimation of total protein in urine. J Lab Clin Med. 1952 Apr;39(4):618–623. [PubMed] [Google Scholar]
  10. Hayes C. P., Jr, Gunnells J. C., Jr Selection of recipients and donors for renal transplantation. Arch Intern Med. 1969 May;123(5):521–530. [PubMed] [Google Scholar]
  11. Häyry P., Defendi V. Allograft immunity in vitro. 3. Induction of deoxyribonucleic acid synthesis in mixed cultures of mouse peripheral lymphocytes from inbred strains differing at non-H-2 loci. Transplantation. 1970 Apr;9(4):410–416. [PubMed] [Google Scholar]
  12. MCKHANN C. F. TRANSPLANTATION STUDIES OF STRONG AND WEAK HISTOCOMPATIBILITY BARRIERS IN MICE. I. IMMUNIZATION. Transplantation. 1964 Sep;2:613–619. doi: 10.1097/00007890-196409000-00002. [DOI] [PubMed] [Google Scholar]
  13. Patel R., Terasaki P. I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969 Apr 3;280(14):735–739. doi: 10.1056/NEJM196904032801401. [DOI] [PubMed] [Google Scholar]
  14. Rowlands D. T., Jr, Burkholder P. M., Bossen E. H., Lin H. H. Renal allografts in HL-A matched recipients. Light, immunofluorescence and electron microscopic studies. Am J Pathol. 1970 Nov;61(2):177–210. [PMC free article] [PubMed] [Google Scholar]
  15. Seigler H. F., Amos D. B., Ward F. E., Andrus C. H., Southworth J. G., Hattler B. G., Jr, Stickel D. L. Immunogenetics of consanguineous allografts in man. I. Histocompatibility testing and skin allografts. Ann Surg. 1970 Aug;172(2):151–159. doi: 10.1097/00000658-197008000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Seigler H. F., Ward F. E., Amos D. B., Phaup M. B., Stickel D. L. The immunogenicity of human HL-A haplotypesas measured by skin graft survival times and mixed leukocyte reactions. J Exp Med. 1971 Mar 1;133(3):411–423. doi: 10.1084/jem.133.3.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Starzl T. E., Boehmig H. J., Amemiya H., Wilson C. B., Dixon F. J., Giles G. R., Simpson K. M., Halgrimson C. G. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med. 1970 Aug 20;283(8):383–390. doi: 10.1056/NEJM197008202830801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stickel D. L., Seigler H. F., Amos D. B., Ward F. E., Gunnells J. C., Jr, Price A. R., Anderson E. E. Immunogenetics of consanguineous allografts in man. II. Correlation of renal allografting with HL-A genotyping. Ann Surg. 1970 Aug;172(2):160–179. doi: 10.1097/00000658-197008000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams G. M., DePlanque B., Lower R., Hume D. Antibodies and human transplant rejection. Ann Surg. 1969 Oct;170(4):603–616. doi: 10.1097/00000658-196910000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Williams G. M., Hume D. M., Hudson R. P., Jr, Morris P. J., Kano K., Milgrom F. "Hyperacute" renal-homograft rejection in man. N Engl J Med. 1968 Sep 19;279(12):611–618. doi: 10.1056/NEJM196809192791201. [DOI] [PubMed] [Google Scholar]
  21. Yunis E. J., Amos D. B. Three closely linked genetic systems relevant to transplantation. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3031–3035. doi: 10.1073/pnas.68.12.3031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yunis E. J., Plate J. M., Ward F. E., Seigler H. F., Amos D. B. Anomalous MLR responsiveness among siblings. Transplant Proc. 1971 Mar;3(1):118–120. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES